NewGenIvf NIVF
NASDAQ NIVF
$0.10 -0.07 (-39.29%)
As of: Oct 1, 2026 · 3:59 PM EDT

NewGenIvf (NIVF) Return on Equity [ROE] (2025)

Updated

NewGenIvf (NIVF) recorded Return on Equity [ROE] of 32.69% in the quarter ended Dec 31, 2025.

Analysis

NewGenIvf (NIVF) Return on Equity [ROE] (2025) Analysis & Trends

For the year ended Dec 31, 2025, NewGenIvf reported Return on Equity [ROE] of 79.40%, up 133.16 percentage points from the prior year.

  • Across earlier years, Return on Equity [ROE] came in at -53.76% in the year ended Dec 31, 2024 (-60.24 pp) and 6.48% in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 HCA Healthcare 93.06 Bn 92.50 Bn - -
2 Natera 59.36 Bn 55.04 Bn 485.19 Mn -10.70%
3 Quest Diagnostics 25.72 Bn 24.15 Bn 1.03 Bn 14.38%
4 Labcorp Holdings 24.93 Bn 22.69 Bn 1.11 Bn 11.58%
5 Guardant Health 23.83 Bn 19.89 Bn 219.03 Mn -
6 Tenet Healthcare 20.58 Bn 11.72 Bn - 47.84%
7 Tempus AI 14.35 Bn 11.38 Bn 246.50 Mn -57.32%
8 Encompass Health 11.99 Bn 12.46 Bn - 24.83%
9 BrightSpring Health Services 11.21 Bn 9.55 Bn 492.75 Mn 18.16%
10 NewGenIvf 4,552.26 -4.69 Mn 524,025.00 32.69%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 32.69%
API Access

NewGenIvf Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NIVF&period=max&api_key=YOUR_API_KEY